Basel Medical Group Ltd (NASDAQ:BMGL) Short Interest Update

Basel Medical Group Ltd (NASDAQ:BMGL) saw a large decline in short interest during the month of December. As of December 31st, there was short interest totaling 150,845 shares, a decline of 24.5% from the December 15th total of 199,691 shares. Approximately 0.8% of the company’s shares are sold short. Based on an average trading volume of 75,100 shares, the short-interest ratio is presently 2.0 days. Based on an average trading volume of 75,100 shares, the short-interest ratio is presently 2.0 days. Approximately 0.8% of the company’s shares are sold short.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Basel Medical Group in a research note on Monday, December 29th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock presently has a consensus rating of “Sell”.

Basel Medical Group Price Performance

BMGL opened at $0.83 on Tuesday. The firm’s fifty day moving average is $0.88 and its two-hundred day moving average is $1.56. Basel Medical Group has a twelve month low of $0.49 and a twelve month high of $9.40. The company has a current ratio of 1.23, a quick ratio of 1.19 and a debt-to-equity ratio of 0.27.

Basel Medical Group (NASDAQ:BMGL) last announced its quarterly earnings results on Monday, November 17th. The company reported ($0.25) earnings per share (EPS) for the quarter. The firm had revenue of $2.60 million for the quarter.

Hedge Funds Weigh In On Basel Medical Group

Several institutional investors have recently modified their holdings of BMGL. Marex Group plc acquired a new position in shares of Basel Medical Group in the 2nd quarter valued at approximately $25,000. Vanguard Personalized Indexing Management LLC acquired a new position in shares of Basel Medical Group in the third quarter valued at approximately $40,000. Virtu Financial LLC boosted its holdings in shares of Basel Medical Group by 108.8% in the third quarter. Virtu Financial LLC now owns 33,786 shares of the company’s stock valued at $61,000 after buying an additional 17,608 shares during the period. Finally, Citadel Advisors LLC bought a new stake in shares of Basel Medical Group during the third quarter worth $169,000.

Basel Medical Group Company Profile

Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.